Accurate and timely detection of bacterial pathogens will improve the clinical management of infections. Herein, we demonstrate an electrochemical biosensor that directly detects bacteria in human blood samples, resulting in the rapid diagnosis of a bloodstream infection. The multiplex biosensor detects the species-specific sequences of the 16S ribosomal RNA of bacteria for pathogen identification in physiological samples without preamplification. The analytical performance characteristics of the biosensor, including the limit of detection and probe cross-reactivity, are evaluated systematically. The feasibility of the biosensor for a diagnosis of a bloodstream infection is demonstrated by identifying bacterial clinical isolates spiked in whole blood and blood culture samples that were tested positive for bacteria. The electrochemical biosensor correctly identifies all the species in the samples with 100% concordance to microbiological analysis.
Introduction
Sepsis is a severe bloodstream infection with a mortality rate over 30% and represents a major public health burden with over one million incidences per year in the United States. 1, 2 Bacteremia, the presence of bacteria in the bloodstream, can occur when bacteria enter into the bloodstream during surgery and dental procedures. Sepsis is most commonly caused by an infection in other parts of the body, such as the urinary tract, lung (e.g., pneumonia), and abdomen. 3 For hospitalized patients, urinary catheters, bed sores, surgical incisions, and intravenous lines are common sites of infection leading to bloodstream infection. Patients with severe wounds, compromised immune systems, and diabetes are particularly susceptible to bloodstream infection. Bloodstream infection can lead to vigorous immune response, systemic inflammation, shock, and organ dysfunction. 4 If left untreated, bloodstream infection can rapidly become life-threatening.
Rapid etiological diagnosis with sensitivities to determine appropriate antimicrobial treatment is essential for the proper clinical management of bloodstream infection. When bloodstream infection is suspected in a patient, blood cultures are used to detect the presence of bacteria. The Surviving Sepsis Campaign, sponsored by the Society for Critical Care Medicine, is a global initiative tasked with improving the management of patients with sepsis. One of the main recommendations is to encourage the administration of broad-spectrum antimicrobial therapy within the first hour of sepsis. 5 After identification of the causative bacteria, treatment can be narrowed to a specific antimicrobial that is effective against the bacterium. Targeted antibiotics treatment has shown to improve the patient outcome and lower the mortality rate compared with a broadspectrum therapy. 6, 7 Since bacterial bloodstream infections initially involve unknown species of bacteria at the time of clinical presentation, there is a need to develop a method for rapidly identifying the bacteria in the blood sample. The identification of bacterial pathogens recovered in positive blood culture often requires cumbersome procedures, such as gram staining, additional subculture, and overnight incubation to obtain isolated colonies for further testing. To address the issues, molecular techniques, such as fluorescence in situ hybridization, nucleic acid amplification, and high-resolution melt curve analysis, have been developed for rapid identification of the bacteria directly from blood cultures. [8] [9] [10] The ability to rapidly identify bacteria in blood will accelerate the diagnosis process, allowing patients to receive timely appropriate antimicrobial treatment.
In this study, we report a multiplex electrochemical biosensor for rapid pathogen identification in blood samples. Electrochemical biosensors represent a sensitive, low-cost strategy for molecular diagnostics. 11, 12 The electrochemical sensor is robust to the matrix effects of physiological samples, which allows direct detection of bacteria in raw physiological samples. [13] [14] [15] [16] [17] The electrochemical sensing platform is portable and therefore it is feasible for this testing to be done at the bedside, at the point of care. The assay does not require nucleic acid amplification, which minimizes false positives due to nonspecific amplification. This study seeks to evaluate the multiplex electrochemical biosensor for measuring and identifying bacterial pathogens, including Staphylococcus aureus (SA), Escherichia coli (EC), Pseudomonas aeruginosa (PA), and Proteus mirabilis (PM). 18 The analytical performance characteristics of the multiplex electrochemical sensor for bacterial detection were studied systematically. The feasibility of the multiplex biosensor for bloodstream infection diagnosis was evaluated by spiking bacterial clinical isolates in whole blood and then testing blood culture bottles that grew bacteria on microbiologic culture.
Methods

Reagents and Samples
Six pairs of oligonucleotide probe pairs (defined in Table  1 ), including four specific probe pairs for EC, SA, PA, and PM; one Enterobacteriaceae (EB) probe pair for all EB; and a universal (UNI) probe pair for detecting the presence of all bacteria, were evaluated. 19 The probes were synthesized by Integrated DNA Technologies (Coralville, IA). The capture and detector probes were modified with thiol and fluorescein at the 5′ end and 3′ end, respectively ( Table 1) . Four clinical isolates (EC, PA, PM, and SA) were obtained from the clinical microbiology laboratory at the Veterans Affairs Palo Alto Health Care System (VAPAHCS). The bacterial colonies were freshly incubated in Luria broth (LB) media and grown to logarithmic phase before the experiment. Human whole blood for spiking experiments was obtained from Innovative Research Inc. (Novi, MI). De-identified EC-positive blood culture samples were obtained from the clinical microbiology laboratory at the Penn State Hershey Medical Center.
Electrochemical Sensors
Gold electrodes for electrochemical sensing were fabricated by sputtering with a shadow mask on plastic substrates. Each chip consisted of 16 sensors. The thiolated capture probes were immobilized on the gold sensor surface by self-assembly. Briefly, 6 µL of 0.05 µM thiolated capture probe and 300 µM hexanedithiol (HDT) in TE buffer (Tris-EDTA, 1X) were spotted on the working electrode and incubated overnight at 4 °C. After washing with water and drying with nitrogen gas, 6 µL of 1 mM 6-mercapto-1 hexanol (MCH) solution was spotted on the working electrode and incubated for 50 min at room temperature. A laser machining system (VLS2.30; Universal Laser System, Scottsdale, AZ) was used to create plastic wells for the electrochemical biosensor. Each sensor received 50 µL of substrate solution for amperometric sensing. The current signal was measured by a multichannel potentiostat. A negative control, LB medium or blood, was included on each sensor chip. 
Detection of Bacterial 16S Ribosomal RNA
Pathogen Identification in Spiked Blood
For detection in whole blood, four times the volumes of each reagent and sample were used. The larger volume was required to generate adequate solution for pipetting onto the sensor. To spike bacteria in blood, the bacterial samples were centrifuged to remove the media and resuspended in blood. The concentration of the spiked samples was ~10 8 colony-forming units (CFU)/mL. Each chip was immobilized with a capture probe. The samples with the detector probes were loaded to the sensor chips with the corresponding capture probes. To test the ability of the multiplex electrochemical sensor for bloodstream infection diagnosis, 40 blood samples were prepared by spiking different bacteria species into whole blood. The bacteria concentrations were on the order of 10 7 and 10 8 CFU/mL.
Results and Discussion
Amperometric Detection of 16S Ribosomal RNA Electrochemical biosensing was performed using a portable, multichannel potentiostat (Fig. 1A) . The multiplex electrochemical sensor chip consisted of 16 gold sensor electrodes with reference and auxiliary electrodes surrounding a circular working electrode (Fig. 1B) . Each biosensor was coated with a self-assembled monolayer consisting of HDT, MCH, and a thiolated capture probe. 20 The multiplex electrochemical sensor used a sandwich binding scheme with a capture probe and a detector probe for detecting the target 16S ribosomal RNA (rRNA) (Fig. 1C) . The target 16S rRNA was immobilized by the capture probe and was detected by the detector probe bound with HRP. The HRP catalyzes the redox reaction to generate an amperometric signal with the addition of TMB and H 2 O 2 substrates. An example of the current outputs of 16 electrochemical sensors simultaneously is shown in Figure 2A .
Analytical Performance of the Electrochemical Biosensor
The analytical performance of the multiplex electrochemical biosensor was first investigated and optimized in media.
A serial dilution experiment was performed to determine the signal levels of EC from 10 4 to 10 8 CFU/mL. The sensor signal correlated with the concentration of EC for over four orders of magnitude (Fig. 2B) . Fitting the data with the power law revealed a limit of detection (blank + 3× standard deviation) of 290 CFU/mL in culture media. The ability of the electrochemical biosensor for pathogen identification in whole blood was then examined. EC, PA, PM, SA, and mixtures of all four bacteria (MIX) were spiked in blood. The samples were detected using sensor chips with specific probe pairs (EC-chip, PA-chip, SA-chip, and PM-chip). A universal probe pair targeting the conserved region of the bacterial 16S rRNA was also included in the experiment (UNI-chip). Figure 2C shows the results for detecting different bacteria with each chip. The multiplex biosensor detected the target pathogens with signal levels significantly higher than the blank (blood only) and nonspecific bacteria, suggesting a low cross-reactivity between the probes. The background level of the blank (whole blood) was approximately 35 nA for target-specific chips (EC, PM, PA, and SA). The signal level for nonspecific target increased to ~66 nA. In this study, a threshold value of 100 nA was defined to identify the existence of a pathogen in the sample.
The UNI-chip successfully detected the existence of bacteria in all samples (Fig. 2C) . In agreement, the highest signal was observed when all four bacteria were mixed in the sample. In a clinical setting, the UNI probe is beneficial for first determining whether a bacterial infection is present, in contrast to false-positive or fungal infection. More important, the UNI probe is designed based on the conserved region of the bacterial 16S rRNA and can indicate the existence of bacteria when a specific probe is not available.
Optimization for Bloodstream Infection Diagnostics
Several aspects were considered in the design of the multiplex biosensor for bloodstream infection diagnostics. The multiplex electrochemical biosensor is designed to detect both gram-negative and gram-positive bacteria. For instance, SA is commonly observed in bloodstream infection. 21 Without lysostaphin, a low signal was obtained due to the inefficiency in lysing the bacteria. Lysostaphin was, therefore, added in the lysis solution for cleaving the cell wall of staphylococci in all samples. Furthermore, a challenge of detecting bacteria in whole blood was coagulation and thickening of the sample after the addition of sodium hydroxide. Although an anticoagulant or a large volume of dilution buffer could be added to the sample, these procedures could reduce the signal-to-noise ratio of the biosensor. To facilitate pipetting of the sample, a larger volume was prepared in the protocol. At least four times the volumes of each reagent and sample were prepared to address the issue.
A test procedure was developed to demonstrate the ability of the multiplex electrochemical sensor for pathogen identification (Fig. 3) . UNI, EB, EC, PM, SA, and PA probes were precoated on the sensor chips. In the first step, the samples were tested with the UNI-chip to detect the existence of bacterial pathogens in the samples. If the samples were positive, the samples were tested with the EB-chip to determine if the bacteria was Enterobacteriaceae or not. If the samples were EB positive, the samples were tested with the EC-chip and the PM-chip. If the samples were EB negative, the samples were tested with the PA-chip and SA-chip.
Pathogen Identification with Clinical Isolates Spiked in Whole Blood
We designed a spiking study to test the ability of the electrochemical biosensor to detect bacteria in blood samples. Three common bacteria (EC, PA, and SA) were spiked into 30 blood specimens. Fifteen samples were spiked with EC, eight samples were spiked with PA, and seven samples were spiked with SA. In addition, 10 blood samples were included as a negative control. All 40 samples were first tested using the UNI-chip (Fig. 4A) . The 30 positive and 10 negative samples were correctly identified using the threshold value. In the second step, the 30 UNI-positive specimens were detected using the EB-chip (Fig. 4B) . The EB-chip had high signals for the 15 EC specimens and low signals for the eight PA and seven SA specimens. In the third step, the EC-chip and PM-chip were applied to detect the 15 EB-positive specimens, and the PA-chip and SA-chip were applied to detect the 15 EB-negative specimens (Fig. 4C-F) . The chips correctly identified all EC, PA, and SA samples. For a nonspecific target, the signal levels were below 25 nA for all sensors, compared with the threshold value of 100 nA for positive detection. These results support the selectivity of the species-specific probes for bloodstream infection diagnostics. 
Electrochemical Biosensors for Positive Blood Cultures
To evaluate the feasibility of the multiplex electrochemical sensor for bloodstream infection diagnosis, samples from positive blood culture bottles were tested. The samples were confirmed to be positive for EC in the clinical microbiology laboratory. All samples were first tested with the UNI-chip (Fig. 5A) . The signals were over 100 nA in all the sensors, suggesting the existence of the bacterial pathogens in the samples. The EB-chip was then applied and resulted in high signals for all samples (Fig. 5B) . Since all samples were EB positive, only the EC-chip and PM-chip were used in the third step (Fig. 5C) . In agreement with the microbiological analysis, all samples were positive for EC and negative for PA. Overall, the multiplex electrochemical sensor correctly identified EC in all blood cultures (Fig. 6A) . Since a large variation was observed among different samples, a plate count was performed to estimate the concentration of bacteria in the samples (Fig. 6B) . A positive correlation was obtained between the plate count and current signals from the UNI-chip and EC-chip (UNI-chip, n = 10, R 2 = 0.775, p = 0.0008; EC-chip, n = 10, R 2 = 0.654, p = 0.00462).
Discussion
In this study, we investigated the performance of a multiplex electrochemical biosensor for pathogen identification toward the rapid and point-of-care diagnosis of bacteremia. A small number of bacteria were tested as a proof of concept to evaluate the feasibility of the assay. In the future, several areas of improvement can be implemented to enhance the clinical significance of the biosensor. In particular, the panel of species-specific probe pairs should be expanded significantly to identify other bacteria that can result in human infections, such as Klebsiella, Enterobacter, Serratia, Citrobacter, and Enterococcus, for bloodstream and infections of other sites. Other bacterial pathogens should also be tested to evaluate the performance of the biosensor. Compared with other bacterial identification technology, the electrochemical biosensing system is portable and has a small footprint. Implementing the assay in an automated format, such as robotic and microfluidic systems, will facilitate the application of the biosensor in a clinical setting. 22, 23 Sample preparation and enrichment modules can also be integrated in the system to improve the limit of detection and enhance the clinical applicability of the biosensor. 24 In the current procedure, the chips with different probe pairs were sequentially tested using different chips in a few hours. As the most rapid results are essential, different probes can be immobilized on the same chip to identify the pathogen within 1 h.
In conclusion, this study examines the feasibility of a multiplex electrochemical biosensor for pathogen identification toward rapid diagnosis of bloodstream infections. The sensor successfully identified bacterial species in spiked blood samples and positive blood cultures from the clinical microbiology laboratory. The system can accelerate the identification of bacterial pathogens in positive blood cultures and may improve the clinical management of bacteremia and sepsis by providing appropriate and timely antimicrobial treatment. 
